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INTRODUCTION  
Oesophageal cancer is the 8th most common type of cancer in the world and the 6th most 
common cancer-related cause of death. Age of onset is most commonly between 65 and 70 
years, with a strong male predominance (2–4:1 male to female).[1] Oesophageal cancer has 
two main histological types with different causes and patterns of incidence; adenocarcinoma 
and squamous cell carcinoma. The incidence of adenocarcinoma has increased rapidly over 
the past decade, now having surpassed the incidence of squamous cell carcinoma.[2] The main 
risk factors for adenocarcinoma of the oesophagus are obesity, gastro-oesophageal reflux 
disease, Barrett’s oesophagus and being male, whereas smoking and high alcohol 
consumption are the main risk factors for squamous cell carcinoma.[3] 
 Due to the expandable nature of the oesophagus, a tumour may remain 
undetected for some time. Consequently oesophageal cancer is often diagnosed at a late stage 
and the prognosis is very poor, with an overall 5-year survival of 10% in Europe.[4] The most 
established curatively intended treatment to date involves extensive surgical resection; 
oesophagectomy with eradication of local and regional lymph nodes, either via a transthoracic 
or a transhiatal approach, often in combination with neoadjuvant therapy.[5-7] However, only 
approximately 25% of patients are eligible for potentially curative surgery as the remaining 
have more advanced disease, poor fitness and pre-existing co-morbidities.[8] The surgery is 
more extensive than any other standard surgical procedure, and up to half of all patients 
experience severe post-operative complications that typically require a long convalescence 
period and severely impact health-related quality of life (HRQL) in the long-term.[9-11] The 
prognosis is unfavourable even when the tumour is surgically removed, with a post-operative 
5-year survival rate of 31%.[8]  
 
4 
 
CURRENT POSITION 
Oesophageal cancer patients experience not only serious physical consequences of their 
disease and treatment but also substantial psychological trauma. Although one third of all 
cancer patients are estimated to suffer from some type of psychiatric disorder during active 
treatment,[12] most research to date investigating oesophageal cancer patients’ recovery 
following surgery has focused largely on impaired functions and symptoms experienced. 
Previous studies show that patients suffer greatly reduced HRQL as a consequence of the 
disease and treatment, both in the short- and long-term.[13] Among long-term survivors, the 
majority of patients recover in terms of HRQL to a level comparable with the background 
population within 3 to 5 years.[14] However, for a minority of long-term survivors, symptoms 
and functions remain impaired or deteriorate even further.[15] Emotional function is one 
HRQL domain that appear to improve over time,[16, 17] particularly among elderly patients.[18] 
Interestingly, one study found that an improvement in emotional functioning from the time of 
oesophageal cancer diagnosis to 6 months post-treatment was associated with better 
survival.[17] 
 Surprisingly few studies have investigated emotional adjustment more 
specifically among surgically treated oesophageal cancer patients. The prevalence of 
depression was 27% in a longitudinal study including both oesophageal and gastro-
oesophageal junction cancer patients without a history of psychiatric illness.[19] Depression 
was assessed using the Hospital Anxiety and Depression Scale (HADS) following 
oesophageal cancer diagnosis, but prior to treatment decision. The depression prevalence was 
lower among patients who were subsequently treated with curative intent (21%) than among 
the palliative patients (46%). A non-significant trend was observed for an increase in the 
prevalence of depression over 6 months in this study. Depression was unrelated to patient 
characteristics or clinical factors, including treatment regime, however greater functional 
5 
 
impairment was associated with elevated depression symptoms. Using the HADS, similar 
prevalence rates of depression have been observed in other studies including surgically treated 
oesophageal cancer patients only. One recent study found that 24% of patients reported 
depression at a median 45 months following diagnosis, and those patients who reported co-
morbidities were also more likely to be depressed.[20] Further, one longitudinal study of 189 
surgically treated oesophageal cancer survivors at a median time of 48 months following 
diagnosis, reported that depressive symptoms appear to persist or even increase over time. 
None of the depressed patients reported an improvement in depressive symptoms over a 12-
month period in this study.[21] 
Anxiety, like depression, is more frequent among cancer patients than in the 
general population but its incidence varies according to age, sex, type of cancer, tumour stage, 
course of treatment, and time in relation to diagnosis.[22, 23] However, anxiety among 
oesophageal cancer patients following surgical resection has been poorly investigated. The 
prevalence of anxiety was 36% in a sample of surgically treated oesophageal cancer patients 4 
years following diagnosis. Younger patients and patients who reported not having a carer 
were more likely to be anxious.[20] There is also evidence that anxiety symptoms may increase 
over time. One study assessing change in anxiety over time, in a sample of early stage 
oesophageal cancer patients following surgical treatment, found that the majority (55%) of 
patients shifted from reporting no anxiety at study inclusion (median time 45 months post 
diagnosis) to reporting elevated anxiety based on HADS criteria for a probable anxiety 
disorder one year later.[21] Findings from one longitudinal study showed that in contrast to 
depression, which was most elevated during treatment, anxiety was greatest at the time of 
diagnosis, but decreased over time in a mixed sample of palliative and curatively treated 
oesophageal cancer patients.[19] In this study, the prevalence of anxiety, as measured by the 
HADS, ranged from 16% to 34% over a 12-month period. Following an initial decrease in 
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anxiety, a spike in symptoms was observed at 3 months following inclusion in the study, for 
patients treated with curative intent, with rates once again similar to those reported at 
inclusion. Duration of tumour-related symptoms experienced before oesophageal cancer 
diagnosis was associated with elevated anxiety scores at time of inclusion, and female patients 
were more anxious than male patients. Not surprisingly, anxiety strongly co-varied with 
depression. The majority of depressed patients also reported anxiety symptoms (73%) above 
the clinical threshold.  
Some studies also suggest that emotional distress among surgically treated 
oesophageal cancer patients may be influenced by patients’ illness perceptions. Illness 
perceptions refer to the cognitive models and explanations an individual has regarding their 
illness or health condition.[24] Few studies have investigated the role of patients’ illness 
perceptions on subsequent emotional distress, but the limited available evidence suggests that 
patients who perceive greater consequences from their condition and report a poorer 
understanding of their cancer, also experience greater anxiety and depression 4 years post-
diagnosis.[20] In this study, patients with stronger perceptions of disease controllability 
reported reduced depression symptoms. Both anxiety and depression symptoms were elevated 
when patients perceived the cause of their illness to be emotional (e.g. stress or worry), but 
decreased if the cause was perceived to be external (e.g. hereditary or a virus). Weaker 
perceptions over time in terms of personal and treatment control over the cancer were 
associated with significantly increased anxiety and depression symptoms over a 12-month 
period, independent of a range of demographic and clinical variables. Additionally, patient 
anxiety was also influenced by the illness perceptions of the spouses. In particular, stronger 
perceptions of greater consequences of the cancer among spouses were associated with 
increased patient anxiety. Poorer understanding of the cancer increased depression in the 
patients, but even more so when the spouse perceived that the patient’s understanding of the 
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cancer was high.[25] One study of psychological distress among carers of oesophageal cancer 
patients found moderate to severe levels of anxiety (19% and 11%, respectively) and 
depression (8% and 2%, respectively) among carers 46 months following the patient’s 
diagnosis. Psychological distress was lower when the carers more strongly believed that they 
understood the patient’s condition, or more strongly believed that the oesophageal cancer 
patient’s condition could be controlled by treatment or the patient’s own behaviour.[26] 
 
FUTURE DIRECTIONS 
It is clear that emotional distress, as a consequence of oesophageal cancer, has 
received little attention to date. Although limited, the available evidence suggests that 
oesophageal cancer patients experience significant levels of distress both in the short- and 
long-term. Taken together, the proportion of patients reporting anxiety and depression ranges 
from 24% to 64% across studies, and results suggest that greater functional impairment, co-
morbidities, a poorer understanding of the cancer, and a perception of greater consequences of 
the oesophageal cancer on patients’ lives are factors associated with depressed mood, whereas 
perceptions of greater control are associated with lower levels of depressed mood. Anxiety is 
associated with younger age, female gender, the absence of a carer, longer duration of pre-
diagnosis tumour-related symptoms, a poorer understanding of the illness and a perception of 
greater consequences of the cancer. There is also an indication of different trajectories for 
depression and anxiety symptoms, where the former appears more common during the 
treatment phase and the latter at the time of diagnosis. Illness perceptions held by spouses of 
oesophageal cancer patients are also associated with patient distress, suggesting that in order 
to fully understand the emotional consequences of oesophageal cancer, the role of the 
patient’s carer, most often the spouse, should also be taken into account. It is, however, 
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difficult to draw conclusions from the literature due to the predominantly cross-sectional 
designs, the varying assessment times, the small sample sizes, the poor response rates, and the 
presentation of results from combined samples of palliative patients and patients treated with 
curative intent. Further, although the majority of studies used HADS, the most extensively 
validated scale for screening emotional distress in cancer patients, it is important to note that 
the clinical thresholds for anxiety or depression varies across studies, influencing diagnostic 
accuracy.[27]  
In conclusion, there is a clear and substantial need for well-designed, 
prospective, nationwide population-based, representative studies on the emotional distress 
experienced by oesophageal cancer patients following surgical treatment in order to 1) 
establish the prevalence of emotional distress, 2) identify the risk factors for poor emotional 
adjustment following treatment and to establish the impact on recovery, and 3) clarify the role 
of patients’ carers on emotional distress among patients. To reduce the suffering among these 
patients, further research on the emotional consequences of oesophageal cancer is highly 
warranted.  
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